Showing results (241-250 of 338) with videos related to

Sort By:
Pageof 34
The Pediatric Infectious Disease Journal|May 16, 2018
Exposure-Response Analysis of Micafungin in Neonatal Candidiasis: Pooled Analysis of Two Clinical TrialsLaura L Kovanda, Thomas J Walsh, Daniel K Benjamin, et al.
Pediatrics|August 31, 2018
Pediatric Antibacterial and Antifungal Trials From 2007 to 2017Joshua T Thaden, Karen Chiswell, Ian Jaffe, et al.
Journal of Clinical Pharmacology|September 29, 2025
Physiologically Based Pharmacokinetic Modeling of Oxcarbazepine to Characterize Its Disposition in Children with ObesityPatricia D Maglalang, Jaydeep Sinha, Victόria Etges Helfer, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|September 13, 2018
Prevalence and safety of diazoxide in the neonatal intensive care unitKeyaria D Gray, Kathryn Dudash, Carla Escobar, et al.
Therapeutic Drug Monitoring|May 10, 2012
Population pharmacokinetics of piperacillin using scavenged samples from preterm infantsMichael Cohen-Wolkowiez, Daniel K Benjamin, Ashley Ross, et al.
Journal of Pediatric Intensive Care|November 17, 2022
Use of Electronic Health Records to Identify Exposure-Response Relationships in Critically Ill Children: An Example of Midazolam and DeliriumKanecia O Zimmerman, Tracy G Spears, Marjan Cobbaert, et al.
Journal of the Pediatric Infectious Diseases Society|December 26, 2023
Diagnostic Utility of Cerebrospinal Fluid White Blood Cell Components for the Identification of Bacterial Meningitis in InfantsAshley E Lamb, Sharla Rent, Asia J Brannon, et al.
The Pediatric Infectious Disease Journal|June 20, 2024
Postdiscontinuation Antibiotic Exposure in Hospitalized Infants at Risk for Late-onset Sepsis in the Neonatal Intensive Care UnitKelly C Wade, Rachel G Greenberg, Daniel K Benjamin, et al.
Antimicrobial Agents and Chemotherapy|March 27, 2019
Rifampin Pharmacokinetics and Safety in Preterm and Term InfantsP Brian Smith, C Michael Cotten, Mark L Hudak, et al.
Pageof 34